Overweight Clinical Trial
— PacDASHOfficial title:
Pacific Kids DASH for Health
Verified date | November 2011 |
Source | Kaiser Permanente |
Contact | n/a |
Is FDA regulated | No |
Health authority | United States: Institutional Review Board |
Study type | Interventional |
The increasing prevalence of childhood overweight has been found to be related to decreased
levels of physical activity (PA) and increased energy content of the diet. Childhood offers
an opportunity to develop and support health-promoting behaviors. Pacific Kids DASH for
Health (PacDASH) is a community-based intervention that links food, PA, and health, and
targets overweight children in Hawaii with a goal of preventing further weight gain.
Components of the intervention include a food and PA prescription delivered by physicians at
community-based health centers complemented with a toolbox of activities, behaviorally
tailored messages, and PacDASH educational materials. This project will extend and apply the
nationally recommended DASH eating pattern to children and the growing population of Asians
and Pacific Islanders. The investigators will incorporate culturally preferred foods,
recipes, and PA messages that meet DASH and other national guidelines. The approach will
target child food behaviors and social and environmental cues that are important to making
healthy food and PA choices and will provide steps to behavior change. Farmers markets at
participating health centers are a support resource for activities. Providing access to,
coupons for, and guidance about selecting and preparing fresh fruits and vegetables at a
convenient health center farmers market will support increased intake of nutrient-rich foods
among these children who are overweight and at risk for obesity.
Pacific Islanders are among the world's most obese populations while Asians, although of
relatively low body mass index (BMI), carry much of their body fat in the upper body and
exhibit greater health risk at the same BMI. Through this project, the investigators hope to
learn more about body size and composition in children of the Pacific Region for whom there
are few national data. In addition, evaluate the effectiveness of a community-based
intervention within a health care system on managing overweight in children.
Status | Completed |
Enrollment | 88 |
Est. completion date | February 2013 |
Est. primary completion date | December 2012 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Both |
Age group | 5 Years to 8 Years |
Eligibility |
Inclusion Criteria: 1. Age 5 - 8 years old 2. >85th up to 98th BMI-for-age percentile (overweight) 3. Children with a primary care provider at MAP 4. Lives on Oahu 5. Due for, or scheduled for, a well-child/physical exam visit during months of the pilot study Exclusion Criteria: 1. Diabetes Mellitis 2. Polycystic Ovarian Syndrome 3. Gastroesophageal Reflux 4. Gallbladder disease 5. Non alcoholic fatty liver disease 6. Pseudo Tumor cerebri 7. Slipped capital femoral epiphysis 8. Blount's disease 9. Obstructive Sleep Apnea/Sleep Disturbance 10. Other chronic disease conditions that would affect participation |
Allocation: Randomized, Intervention Model: Single Group Assignment, Masking: Single Blind (Subject)
Country | Name | City | State |
---|---|---|---|
United States | Kaiser Permanente Center for Health Research, Hawaii | Honolulu | Hawaii |
Lead Sponsor | Collaborator |
---|---|
Kaiser Permanente | University of Hawaii |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Develop/evaluate effectiveness of a community-based intervention targets children of the Pacific Region who are overweight in order to slow and prevent further weight gain (for children to "grow into their weight") | Feb 2008 - Feb 2012 | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
Terminated |
NCT03299881 -
Safety and Effectiveness of Transcutaneous Electrical Nerve Stimulation (TENS)-Assisted Weight Loss
|
N/A | |
Completed |
NCT02805478 -
Fat-Associated Cardiovascular Organ Dysfunction
|
||
Active, not recruiting |
NCT02558920 -
Meta-analyses of Food Sources of Fructose-Containing Sugars and Obesity
|
||
Completed |
NCT03759743 -
Evaluate the Efficacy and Safety of LMT1-48 on Reducing Body Fat in Overweight Subject
|
N/A | |
Completed |
NCT03610958 -
Safety and Performance Evaluation of the Epitomee Device for Enhancing Satiety and Weight Loss.
|
N/A | |
Completed |
NCT03678766 -
CHARGE: Controlling Hunger and ReGulating Eating
|
N/A | |
Completed |
NCT04430465 -
Effects of Wholegrains on Children's Health (KORN)
|
N/A | |
Completed |
NCT04117802 -
Effects of Maple Syrup on Gut Microbiota Diversity and Metabolic Syndrome
|
N/A | |
Completed |
NCT05376865 -
Effects of Vitamin D Supplementation on Obesity, Inflammatory and Metabolic Markers
|
N/A | |
Completed |
NCT03625427 -
Effect of Palmitoleic Acid on C-reactive Protein
|
N/A | |
Active, not recruiting |
NCT03435445 -
Online Platform for Healthy Weight Loss (POEmaS)
|
N/A | |
Enrolling by invitation |
NCT05576116 -
Combined Bariatric Surgery and Pancreas After Kidney Transplantation for Type II Diabetics
|
N/A | |
Recruiting |
NCT05249465 -
Spark: Finding the Optimal Tracking Strategy for Weight Loss in a Digital Health Intervention
|
N/A | |
Active, not recruiting |
NCT06023095 -
A Study of LY3502970 in Chinese Participants With Obesity or Are Overweight With Weight-related Comorbidities
|
Phase 1 | |
Completed |
NCT03648892 -
Brain Dopamine Function in Human Obesity
|
Early Phase 1 | |
Not yet recruiting |
NCT05751993 -
Piloting a Reinforcement Learning Tool for Individually Tailoring Just-in-time Adaptive Interventions
|
N/A | |
Recruiting |
NCT02887950 -
Resistant Starch, Epigallocatechin Gallate and Chlorogenic Acid for Body Weight Loss in Menopause
|
N/A | |
Completed |
NCT03097237 -
High Fiber Rye Foods for Weight and Body Fat Reduction
|
N/A | |
Terminated |
NCT02743598 -
Liraglutide for HIV-associated Neurocognitive Disorder
|
Phase 4 |